Search

Search Results

• “IDENTIFYING HIGH-RISK CHRONIC LYMPHOCYTIC LEUKEMIA: A PATHOGENESIS-ORIENTED APPRAISAL OF PROGNOSTIC AND PREDICTIVE FACTORS IN PATIENTS TREATED WITH CHEMOTHERAPY WITH OR WITHOUT IMMUNOTHERAPY.”

  Sara Martinelli, Antonio Cuneo, Gian Matteo Rigolin

  e2016047

  2016-10-15

  https://doi.org/10.4084/mjhid.2016.047

  4064

  PDF: 1100

  HTML: 3899

  Untitled: 189

  Cneo. Fig.1: 127

  Untitled: 122

  Untitled: 147

  Untitled: 156

• Response to ibrutinib of a refractory IgA lymphoplasmacytic lymphoma carrying the MYD88 L265P gene mutation

  Francesca Maria Quaglia, Gian Matteo Rigolin, Elena Saccenti, Massimo Negrini, Eleonora Volta, Melissa Dabusti, Maria Ciccone, Antonio Urso, Michele Laudisi, Antonio Cuneo

  e2019057

  2019-08-29

  https://doi.org/10.4084/mjhid.2019.057

  1656

  PDF: 999

  HTML: 299

• THERAPEUTIC TARGETING OF NOTCH SIGNALING PATHWAY IN HEMATOLOGICAL MALIGNANCIES

  Giovanni Roti, Claudia Sorrentino, Antonio Cuneo

  e2019037

  2019-06-25

  https://doi.org/10.4084/mjhid.2019.037

  2267

  PDF: 1639

  HTML: 617

• NURSES’ PHYSICAL AND PSYCHOLOGICAL SYMPTOMS DURING THE FIRST COVID-19 LOCKDOWN IN ITALY A nationwide cross-sectional study in stem cell transplantation setting.

  Stefano Botti, Chiara Cannici, Sarah Liptrott, Valentina De Cecco, Elena Rostagno, Gianpaolo Gargiulo, Laura Orlando , Caime Alessandro, Emanuela Samarani, Letizia Galgano, Marco Cioce, Nicola Mordini, Nadia Mandelli, Lucia Tombari, Sara Errichiello, Nicola Celon, Roberto Lupo; Teresa Rea; Nicola Serra

  e2022010

  2022-01-01

  https://doi.org/10.4084/MJHID.2022.010

  2242

  PDF: 878

  HTML: 371

• RELAPSED/REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA: CHEMOIMMUNOTHERAPY, TREATMENT UNTIL PROGRESSION WITH MECHANISM-DRIVEN AGENTS OR FINITE-DURATION THERAPY?

  Antonio Cuneo, Robin Foà

  e2019024

  2019-02-27

  https://doi.org/10.4084/mjhid.2019.024

  2799

  PDF: 1706

  HTML: 396